T1	Participants 497 568	Twenty-one consecutive obese patients with heart failure were recruited
T2	Participants 246 329	patients with heart failure can benefit from losing weight via an orlistat-assisted
T3	Participants 376 424	obese patients with ejection fractions < or =40%
